271 related articles for article (PubMed ID: 28092725)
1. Strontium ranelate, a promising disease modifying osteoarthritis drug.
Han W; Fan S; Bai X; Ding C
Expert Opin Investig Drugs; 2017 Mar; 26(3):375-380. PubMed ID: 28092725
[TBL] [Abstract][Full Text] [Related]
2. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
3. What about strontium ranelate in osteoarthritis? Doubts and securities.
Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
Mod Rheumatol; 2014 Nov; 24(6):881-4. PubMed ID: 24645726
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial.
Cooper C; Reginster JY; Chapurlat R; Christiansen C; Genant H; Bellamy N; Bensen W; Navarro F; Badurski J; Nasonov E; Chevalier X; Sambrook PN
Curr Med Res Opin; 2012 Feb; 28(2):231-9. PubMed ID: 22148897
[TBL] [Abstract][Full Text] [Related]
5. Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review.
Rodrigues TA; Freire AO; Bonfim BF; Cartágenes MSS; Garcia JBS
Braz J Med Biol Res; 2018; 51(8):e7440. PubMed ID: 29924137
[TBL] [Abstract][Full Text] [Related]
6. Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model.
Yu DG; Ding HF; Mao YQ; Liu M; Yu B; Zhao X; Wang XQ; Li Y; Liu GW; Nie SB; Liu S; Zhu ZA
Acta Pharmacol Sin; 2013 Mar; 34(3):393-402. PubMed ID: 23334238
[TBL] [Abstract][Full Text] [Related]
7. Investigational drugs for the treatment of osteoarthritis.
Wang K; Xu J; Hunter DJ; Ding C
Expert Opin Investig Drugs; 2015; 24(12):1539-56. PubMed ID: 26429673
[TBL] [Abstract][Full Text] [Related]
8. Different doses of strontium ranelate and mechanical vibration modulate distinct responses in the articular cartilage of ovariectomized rats.
Mierzwa AGH; Campos JF; Jesus MF; Nader HB; Lazaretti-Castro M; Reginato RD
Osteoarthritis Cartilage; 2017 Jul; 25(7):1179-1188. PubMed ID: 28223125
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate causes osteophytes overgrowth in a model of early phase osteoarthritis.
Chu JG; Dai MW; Wang Y; Tian FM; Song HP; Xiao YP; Shao LT; Zhang YZ; Zhang L
BMC Musculoskelet Disord; 2017 Feb; 18(1):78. PubMed ID: 28187731
[TBL] [Abstract][Full Text] [Related]
10. An OA phenotype may obtain major benefit from bone-acting agents.
Roman-Blas JA; Castañeda S; Largo R; Lems WF; Herrero-Beaumont G
Semin Arthritis Rheum; 2014 Feb; 43(4):421-8. PubMed ID: 24016748
[TBL] [Abstract][Full Text] [Related]
11. Meniscal extrusion promotes knee osteoarthritis structural progression: protective effect of strontium ranelate treatment in a phase III clinical trial.
Roubille C; Martel-Pelletier J; Raynauld JP; Abram F; Dorais M; Delorme P; Pelletier JP
Arthritis Res Ther; 2015 Mar; 17(1):82. PubMed ID: 25888851
[TBL] [Abstract][Full Text] [Related]
12. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments?
Karsdal MA; Bay-Jensen AC; Lories RJ; Abramson S; Spector T; Pastoureau P; Christiansen C; Attur M; Henriksen K; Goldring SR; Kraus V
Ann Rheum Dis; 2014 Feb; 73(2):336-48. PubMed ID: 24285494
[TBL] [Abstract][Full Text] [Related]
13. Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
Bruyère O; Reginster JY; Bellamy N; Chapurlat R; Richette P; Cooper C;
Rheumatology (Oxford); 2014 Aug; 53(8):1457-64. PubMed ID: 24667161
[TBL] [Abstract][Full Text] [Related]
14. The action of Strontium ranelate: myth or reality.
Bunyaratavej N
J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S35-7. PubMed ID: 22338924
[TBL] [Abstract][Full Text] [Related]
15. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort.
Mohan G; Perilli E; Parkinson IH; Humphries JM; Fazzalari NL; Kuliwaba JS
Osteoarthritis Cartilage; 2013 Oct; 21(10):1595-604. PubMed ID: 23827368
[TBL] [Abstract][Full Text] [Related]
16. [Research progress of effects of strontium ranelate on osteoarthritis].
Wang Y; Dai M; Tian F; Zhang L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1479-83. PubMed ID: 25826890
[TBL] [Abstract][Full Text] [Related]
17. Effect of strontium ranelate on bone remodeling.
Rodríguez J; Escudero ND; Mandalunis PM
Acta Odontol Latinoam; 2012; 25(2):208-13. PubMed ID: 23230643
[TBL] [Abstract][Full Text] [Related]
18. [Research progress of protective effects of alendronate on articular cartilage in osteoarthritis].
He D; Yin M; Luo Y; Wei Q
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Oct; 26(10):1187-90. PubMed ID: 23167100
[TBL] [Abstract][Full Text] [Related]
19. Should subchondral bone turnover be targeted when treating osteoarthritis?
Karsdal MA; Leeming DJ; Dam EB; Henriksen K; Alexandersen P; Pastoureau P; Altman RD; Christiansen C
Osteoarthritis Cartilage; 2008 Jun; 16(6):638-46. PubMed ID: 18362080
[TBL] [Abstract][Full Text] [Related]
20. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
